Law, Politics, and Expert Panels at the US Food and Drug Administration

Key Points

• The central aim is to evaluate the legality and reliability of using expert panels instead of traditional advisory committees at the FDA.
• Analytical viewpoint on the FDA's decision-making process.
• Discussion of legal frameworks governing the FDA.
• Evaluation of credibility concerns related to expert panels.
• Highlights concerns about the legitimacy of expert panels.
• Suggests that using expert panels may undermine public trust.
• Calls for clarity in the FDA's decision-making criteria.